Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

75 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Upper gastrointestinal alarms: the 2-week rule.
van Zanten SV. van Zanten SV. Lancet. 2005 Jun 25-Jul 1;365(9478):2163-4. doi: 10.1016/S0140-6736(05)66757-8. Lancet. 2005. PMID: 15978912 No abstract available.
One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study.
van Zanten SV, Flook N, Talley NJ, Vakil N, Lauritsen K, Bolling-Sternevald E, Persson T, Björck E, Svedberg LE; STARS II Study Group. van Zanten SV, et al. Aliment Pharmacol Ther. 2007 Sep 1;26(5):665-72. doi: 10.1111/j.1365-2036.2007.03409.x. Aliment Pharmacol Ther. 2007. PMID: 17697200 Clinical Trial.
Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin.
Yeomans N, Lanas A, Labenz J, van Zanten SV, van Rensburg C, Rácz I, Tchernev K, Karamanolis D, Roda E, Hawkey C, Nauclér E, Svedberg LE. Yeomans N, et al. Among authors: van zanten sv, van rensburg c. Am J Gastroenterol. 2008 Oct;103(10):2465-73. doi: 10.1111/j.1572-0241.2008.01995.x. Epub 2008 Jul 12. Am J Gastroenterol. 2008. PMID: 18637091 Clinical Trial.
75 results